the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 716 participants.

Also called NCT06653946

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 716 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06653946
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06653946. Non-randomized; no masking; primary purpose treatment. Start 2022-07-01 (actual); primary completion 2024-07-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients
Condition
Alteplase Adverse Reaction
Intervention (Drug)
Alteplase
Intervention (Drug)
Alteplase
Lead sponsor
Kafrelsheikh University (class: other)

Record details

Record id
cardio:ct-nct06653946
Content hash
280f9c191b2606344ba9e3c42a96b39f44cf9a8f6e7d57f2f807bbbce19fbb54